Pharmaceutical • Gene Therapy • Biotech • 24/7 Dispatch
Ground Expedite Freight
Philadelphia & PA
Penn Medicine. GSK. Spark. Merck. CHOP. When pharma freight can’t wait in the Northeast corridor, AB&M dispatches in 30-60 minutes.
By Robert McGrady, General Manager, AB&M Logistics • Updated May 2026
AB&M Logistics dispatches ground expedite freight from Philadelphia for pharmaceutical, gene therapy, and biotech operations across the Northeast pharma corridor — Philadelphia, King of Prussia, Conshohocken, Wilmington DE, and Princeton NJ. AB&M responds within 30-60 minutes, 24/7, with chain-of-custody handling for clinical trial freight, temperature monitoring for cold chain, and qualified-courier hand-carry for ATMP shipments. Operating since 1997 with zero cargo theft or fraud incidents. Call (803) 244-9897.
Ground expedite freight in Philadelphia serves a market where three industries — pharmaceutical manufacturing, gene therapy and biotech, and academic medical research — share the same problem: when freight fails, the cost is measured in clinical trial timelines, FDA submission delays, and stability windows that close in hours.
If you’re searching right now because a shipment is sitting on a dock or a cold-chain milestone is closing, stop reading and call: 803-244-9897. We dispatch in 30 minutes. If you’re building carrier relationships before the next emergency, keep reading — everything below is why Philadelphia is one of AB&M’s highest-priority Northeast markets.
Gene Therapy Capital. Northeast Pharma Corridor. One Expedite Network.
Within 30 minutes of center city Philadelphia, you find the institutions that delivered the first FDA-approved CAR-T cell therapy and the first FDA-approved gene therapy in US history. The Penn Medicine and CHOP campuses sit in West Philadelphia. Spark Therapeutics operates out of West Philly. GSK runs a major Philadelphia campus. Merck headquarters and manufacturing sit just across the Delaware River in New Jersey, and Bristol Myers Squibb is 45 minutes north in Princeton. This is the densest concentration of pharmaceutical and advanced-therapy manufacturing in the United States.
When freight fails inside this corridor, the cost is not measured in dollars per hour. It is measured in clinical trial cohorts that miss enrollment windows, FDA filing dates that slip a quarter, and single-patient ATMP shipments where a temperature excursion ends a treatment course. Ground expedite is not a convenience here. It is the only category of freight movement that fits the operational profile.
Who Operates in Philadelphia — and What’s at Stake When Freight Stops
Penn Medicine and CHOP — Gene Therapy Pioneers
The University of Pennsylvania’s Perelman School of Medicine was the site of the first FDA-approved CAR-T cell therapy in 2017 (tisagenlecleucel, developed through the Penn-Novartis collaboration). Children’s Hospital of Philadelphia (CHOP), adjacent to the Penn campus, runs one of the largest pediatric clinical trial programs in North America and was central to the development of multiple FDA-approved gene therapies.
ATMP (advanced therapy medicinal products) freight from these institutions has stability windows measured in hours — sometimes less. A single-patient autologous cell therapy can carry an economic value measured in six figures and a biological viability window measured in single-digit hours from cryo-thaw. AB&M provides chain-of-custody handling and qualified-courier hand-carry for cell and gene therapy shipments, with the same SOP framework AB&M built for hyperscale data center logistics.
GSK and Merck — Northeast Pharma Manufacturing
GSK operates a major Philadelphia campus on Market Street, and Merck headquarters and manufacturing facilities sit just across the Delaware River in New Jersey. Both companies move pharmaceutical-grade freight through the PHL and Newark cargo gateways daily. A delayed clinical trial drug shipment or a missed cold-chain milestone resets months of FDA submission timeline. AB&M’s Medical & Pharma Expedite service handles the temperature, chain-of-custody, and DSCSA documentation requirements that pharma freight demands.
Spark Therapeutics and the Philadelphia Gene Therapy Hub
Spark Therapeutics, headquartered in West Philadelphia, brought the first FDA-approved gene therapy to market (Luxturna for inherited retinal disease, 2017). The Philadelphia gene therapy hub — including Spark, Iovance, WuXi Advanced Therapies, and the manufacturing ecosystem that surrounds them — produces some of the most freight-sensitive pharmaceutical products in the world. Single-patient ATMP shipments routinely carry seven-figure manufacturing cost and stability windows measured in hours.
Wilmington DE and the I-95 Pharma Corridor
Thirty minutes south of Philadelphia, Wilmington Delaware hosts DuPont, Incyte, AstraZeneca, and a cluster of pharmaceutical R&D operations. The I-95 corridor from Wilmington through Philadelphia to Princeton, New Brunswick, and Newark functions as a single pharmaceutical manufacturing supply chain. AB&M operates this corridor as a single dispatch region with active carrier coverage 24/7.
Philadelphia Corridor Coverage
From Philadelphia, AB&M’s ground expedite network reaches New York and Newark in approximately 1.5 hours via the NJ Turnpike, Washington DC in 2.5 hours via I-95, Boston in 5 hours, Baltimore in 2 hours, Wilmington Delaware in 30 minutes, and Princeton in 45 minutes via I-95. The I-95 corridor between Wilmington, Philadelphia, Princeton, Newark, and New York City is the densest pharmaceutical manufacturing supply chain in North America and the highest-value pharma freight corridor in the country.
King of Prussia and Conshohocken, immediately west and northwest of Philadelphia on the Schuylkill Expressway corridor, sit inside AB&M’s direct dispatch coverage — same 30-minute response as center city Philadelphia. King of Prussia’s historic pharma footprint (GE Healthcare, GSK heritage operations) and Conshohocken’s biotech and pharma services concentration generate emergency freight demand that requires the same response speed as the manufacturing floor.
Philadelphia International (PHL) operates as a major air cargo gateway with same-day Next Flight Out capacity to most US destinations. The Port of Philadelphia handles refrigerated pharmaceutical imports requiring cold-chain transit from container to destination.
SOP-Level Execution Before the Emergency Happens
AB&M Logistics built the dedicated server logistics program for Meta — ESD-compliant, white-glove, full SOP documentation. That same level of pre-planned, protocol-driven execution is what we bring to pharmaceutical and biotech accounts in Philadelphia. We don’t improvise when a clinical trial sample is sitting on a dock at 2am. The carriers are pre-qualified. The routes are pre-mapped. The escalation protocol is already documented.
The call gets answered and the truck is moving within 30 minutes because the decisions have already been made in advance.
That is the difference between a freight broker you find under pressure and a freight partner you established before the emergency. AB&M works both ways — but the accounts we serve best in pharma are the ones that called us before the FDA inspection, not during the supply chain failure.
Philadelphia Expedited Freight — Frequently Asked Questions
David King — Director, Client Partnerships
David King serves on the Board of Directors of the Airforwarders Association (2025–2028) and brings over 20 years of expedited freight experience to AB&M’s operations. He was cited in the AfA’s October 2025 press release calling for a Federal Cargo Theft Task Force. David oversees AB&M’s client partnerships, carrier vetting standards, and operational protocols across all service lines.
Pharma freight stuck in Philadelphia?
Call AB&M. We dispatch in 30 minutes.
24/7, including nights, weekends, and holidays. No voicemail. No hold queue.
24/7 Philadelphia Dispatch